Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men

Psychopharmacology

Volumn 155, Issue 2, 2001, Pages 187-192

  Murck, H ^a   Frieboes, R M ^a   Antonijevic, I A ^a   Steiger, A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

5 HT receptor; 5 HT1A; Adaptive change; Depression; Sleep; SSRI

Indexed keywords

PLACEBO; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VILAZODONE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELTA RHYTHM; DIARRHEA; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLOW WAVE SLEEP; WAKEFULNESS; XEROSTOMIA;

ADULT; BENZOFURANS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; INDOLES; MALE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0035023887     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100703     Document Type: Article

References (35)

1. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients
2. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
3. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
4. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls
5. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties
6. Pindolol augmentation of sertraline in resistant depression and its effect on sleep
7. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats
8. Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y
9. 1A receptors in psychopathology and the mechanisms of action of clinically effective therapeutic agents
10. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra
11. Fluoxetine-induced sleep disturbance in depressed patients
12. The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects
13. The St. Mary's Hospital sleep questionnaire: A study of reliability
14. Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat
15. Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers
16. The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study
17. Clomipramine and EEG sleep in depression
18. Serotonin-2 receptors and human sleep: Effect of a selective antagonist on EEG power spectra
19. Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat
20. Neurobiological structure of the revised limit cycle reciprocal interaction model of REM cycle control
21. Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones
22. Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami
23. Aging does not affect the sleep endocrine response to total sleep deprivation in humans
24. Dose-related suppression of REM sleep and PGO waves by the serotonin-1 agonist eltoprazine
25. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain
26. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
27. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities
28. Central administration of two 5-HT receptor agonists: Effect on REM sleep initiation and PGO waves
29. Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: Desensitization and down-regulation by serotonin
30. The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade
31. Human sleep EEG following the 5-HT1A antagonist pindolol: Possible disinhibition of raphe neuron activity
32. The effects of paroxetine and nef-azodone on sleep: A placebo-controlled trial
33. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression
34. Drug effects on REM sleep and on endogenous depression